Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Clinical trial NCT04137562 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04137562
- Sponsor
- EHL Bio Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2023-01-26
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.